Interstitial Keratitis Secondary to Severe Hidradenitis Suppurativa Responding to Adalimumab Reply

被引：0
|
作者：
Demirci, Hakan [1 ]
Fernandez, Anna G. Alzaga [2 ]
Darnley-Fisch, Deborah A. [2 ]
Steen, Daniel W. [2 ]
机构：
[1] Univ Michigan, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA
[2] Henry Ford Hosp, Dept Ophthalmol, Detriot, MI USA
来源：
CORNEA | 2012年 / 31卷 / 02期
关键词：
D O I：
10.1097/ICO.0b013e31821213a7
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [21] Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa
    van Rappard, Dominique
    Leenarts, Marjolein
    Meijerink-van't Oost, Leonie
    Mekkes, Jan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S42 - S42
  • [22] Successful Treatment of Coexistent Acne Fulminans and Severe Hidradenitis Suppurativa with Adalimumab
    Kontochristopoulos, George
    Agiasofitou, Efthymia
    Platsidaki, Eftychia
    Kapsiocha, Anastasia
    Gregoriou, Stamatios
    Rigopoulos, Dimitrios
    SKIN APPENDAGE DISORDERS, 2021, 7 (04): : 329 - 332
  • [23] Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial
    Kimball, Alexa B.
    Kerdel, Francisco
    Adams, David
    Mrowietz, Ulrich
    Gelfand, Joel M.
    Gniadecki, Robert
    Prens, Errol P.
    Schlessinger, Joel
    Zouboulis, Christos C.
    van der Zee, Hessel H.
    Rosenfeld, Marie
    Mulani, Parvez
    Gu, Yihua
    Paulson, Susan
    Okun, Martin
    Jemec, Gregor B. E.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (12) : 846 - +
  • [24] Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
    Fotiadou, Christina
    Vakirlis, Efstratios
    Ioannides, Dimitrios
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2016, 9 : 367 - 372
  • [25] Distinguishing Mild, Moderate, and Severe Hidradenitis Suppurativa Reply
    Hessam, Schapoor
    Scholl, Lisa
    Sand, Michael
    Schmitz, Lutz
    Reitenbach, Sarah
    Bechara, Falk G.
    JAMA DERMATOLOGY, 2018, 154 (08) : 972 - 972
  • [26] Reply to comment: guselkumab in the treatment of severe hidradenitis suppurativa
    Kovacs, M.
    Podda, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (08) : E300 - E300
  • [27] Effectivity and safety of adalimumab in hidradenitis suppurativa
    Ortiz Salvador, J. M.
    Magdaleno Tapial, J.
    Perez Ferriols, A.
    Giacaman von der Weth, M.
    Saneleuterio Temporal, M.
    Sanchez Carazo, J. L.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 : 44 - 44
  • [28] Hidradenitis suppurativa successfully treated with adalimumab
    Alzahrani, A.
    Bukhari, I.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 12 - 12
  • [29] Resistant hidradenitis suppurativa treated with adalimumab
    Moran, B.
    Rogers, S. C. F.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 57 - 57
  • [30] Flares in hidradenitis suppurativa in treatment with adalimumab
    Caposiena Caro, R. D.
    Bianchi, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (03) : E138 - E139
12345